Clinical trial
An International, Open Label, Randomised Controlled Trial Comparing Rituximab With Azathioprine as Maintenance Therapy in Relapsing ANCA-associated Vasculitis
NCT01697267 is registered in ClinicalTrials.gov with Cambridge University Hospitals NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An International, Open Label, Randomised Controlled Trial Comparing Rituximab With Azathioprine as Maintenance Therapy in Relapsing ANCA-associated Vasculitis
- Lead sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2013
- Completion date
- November 21, 2019
- Enrollment
- 188 (actual)
- Sites
- 38
Conditions
As the registry lists them; a condition with its own page is linked.
anti-neutrophil cytoplasmic antibody-associated vasculitis, microscopic polyangiitis, wegener granulomatosis